GB1330829A - Layered bolus for animal husbandry providing for immediate and sustained release of medicament - Google Patents
Layered bolus for animal husbandry providing for immediate and sustained release of medicamentInfo
- Publication number
- GB1330829A GB1330829A GB2342672A GB2342672A GB1330829A GB 1330829 A GB1330829 A GB 1330829A GB 2342672 A GB2342672 A GB 2342672A GB 2342672 A GB2342672 A GB 2342672A GB 1330829 A GB1330829 A GB 1330829A
- Authority
- GB
- United Kingdom
- Prior art keywords
- sustained release
- bolus
- medicament
- immediate
- release layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000013268 sustained release Methods 0.000 title abstract 9
- 239000012730 sustained-release form Substances 0.000 title abstract 9
- 239000003814 drug Substances 0.000 title abstract 7
- 239000012729 immediate-release (IR) formulation Substances 0.000 title abstract 5
- 241000282849 Ruminantia Species 0.000 abstract 4
- 230000003179 granulation Effects 0.000 abstract 4
- 238000005469 granulation Methods 0.000 abstract 4
- 239000000945 filler Substances 0.000 abstract 3
- 239000008280 blood Substances 0.000 abstract 2
- 210000004369 blood Anatomy 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 1
- 241000195947 Lycopodium Species 0.000 abstract 1
- RHCOJUBIAOBGKL-UHFFFAOYSA-N O(I)I.[Mg] Chemical compound O(I)I.[Mg] RHCOJUBIAOBGKL-UHFFFAOYSA-N 0.000 abstract 1
- 229930182555 Penicillin Natural products 0.000 abstract 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract 1
- 239000011398 Portland cement Substances 0.000 abstract 1
- 235000021355 Stearic acid Nutrition 0.000 abstract 1
- 239000004098 Tetracycline Substances 0.000 abstract 1
- 230000000507 anthelmentic effect Effects 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 abstract 1
- 239000008116 calcium stearate Substances 0.000 abstract 1
- 235000013539 calcium stearate Nutrition 0.000 abstract 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Inorganic materials [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 abstract 1
- PASHVRUKOFIRIK-UHFFFAOYSA-L calcium sulfate dihydrate Chemical compound O.O.[Ca+2].[O-]S([O-])(=O)=O PASHVRUKOFIRIK-UHFFFAOYSA-L 0.000 abstract 1
- ZOMBKNNSYQHRCA-UHFFFAOYSA-J calcium sulfate hemihydrate Chemical compound O.[Ca+2].[Ca+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O ZOMBKNNSYQHRCA-UHFFFAOYSA-J 0.000 abstract 1
- 239000004568 cement Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229960005091 chloramphenicol Drugs 0.000 abstract 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 abstract 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 abstract 1
- 229960001076 chlorpromazine Drugs 0.000 abstract 1
- 229940110456 cocoa butter Drugs 0.000 abstract 1
- 235000019868 cocoa butter Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 abstract 1
- 229960001625 furazolidone Drugs 0.000 abstract 1
- 239000010439 graphite Substances 0.000 abstract 1
- 229910002804 graphite Inorganic materials 0.000 abstract 1
- 239000011507 gypsum plaster Substances 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 abstract 1
- 239000012188 paraffin wax Substances 0.000 abstract 1
- 229940049954 penicillin Drugs 0.000 abstract 1
- NQQWFVUVBGSGQN-UHFFFAOYSA-N phosphoric acid;piperazine Chemical compound OP(O)(O)=O.C1CNCCN1 NQQWFVUVBGSGQN-UHFFFAOYSA-N 0.000 abstract 1
- 229960001954 piperazine phosphate Drugs 0.000 abstract 1
- 210000004767 rumen Anatomy 0.000 abstract 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 abstract 1
- 239000008117 stearic acid Substances 0.000 abstract 1
- ASWVTGNCAZCNNR-UHFFFAOYSA-N sulfamethazine Chemical compound CC1=CC(C)=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ASWVTGNCAZCNNR-UHFFFAOYSA-N 0.000 abstract 1
- 150000003456 sulfonamides Chemical class 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 239000000454 talc Substances 0.000 abstract 1
- 229910052623 talc Inorganic materials 0.000 abstract 1
- 229960002180 tetracycline Drugs 0.000 abstract 1
- 229930101283 tetracycline Natural products 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
- 150000003522 tetracyclines Chemical class 0.000 abstract 1
- 229940125725 tranquilizer Drugs 0.000 abstract 1
- 239000003204 tranquilizing agent Substances 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0068—Rumen, e.g. rumen bolus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14449971A | 1971-05-18 | 1971-05-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1330829A true GB1330829A (en) | 1973-09-19 |
Family
ID=22508878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2342672A Expired GB1330829A (en) | 1971-05-18 | 1972-05-18 | Layered bolus for animal husbandry providing for immediate and sustained release of medicament |
Country Status (10)
| Country | Link |
|---|---|
| AU (1) | AU470023B2 (xx) |
| BE (1) | BE783321A (xx) |
| CA (1) | CA997677A (xx) |
| DE (1) | DE2224390A1 (xx) |
| ES (1) | ES402545A1 (xx) |
| FR (1) | FR2138011B1 (xx) |
| GB (1) | GB1330829A (xx) |
| IE (1) | IE36335B1 (xx) |
| NL (1) | NL7206328A (xx) |
| ZA (1) | ZA722664B (xx) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2500307A1 (fr) * | 1981-02-23 | 1982-08-27 | Rech Applications Therap | Composition pharmaceutique antibiotique concue pour l'implantation dans une cavite naturelle, pathologique ou artificielle des tissus physiologiques, sa preparation et son utilisation |
| GB2155335A (en) * | 1984-03-07 | 1985-09-25 | Crb Virbac Sa | Device for sustained release of medicinal substances |
| US4661339A (en) * | 1982-07-20 | 1987-04-28 | National Research Development Corp. | Sustained release composition |
| US5190760A (en) * | 1989-07-08 | 1993-03-02 | Coopers Animal Health Limited | Solid pharmaceutical composition |
| WO2001032217A2 (en) * | 1999-11-02 | 2001-05-10 | Depomed, Inc. | Pharmacological inducement of the fed mode for enhanced drug administration to the stomach |
| US6682759B2 (en) | 2002-02-01 | 2004-01-27 | Depomed, Inc. | Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs |
| US6723340B2 (en) | 2001-10-25 | 2004-04-20 | Depomed, Inc. | Optimal polymer mixtures for gastric retentive tablets |
| US7736667B2 (en) | 2000-02-04 | 2010-06-15 | Depomed, Inc. | Shell-and-core dosage form approaching zero-order drug release |
| US7976870B2 (en) | 2001-10-25 | 2011-07-12 | Depomed, Inc. | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
| US8685450B2 (en) | 2003-07-18 | 2014-04-01 | Depomed, Inc. | Dual drug dosage forms with improved separation of drugs |
| CN104523636A (zh) * | 2014-12-25 | 2015-04-22 | 昆明振华制药厂有限公司 | 一种呋喃唑酮缓释片及其制备方法 |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4137300A (en) * | 1976-08-20 | 1979-01-30 | Ciba-Geigy Corporation | Sustained action dosage forms |
| NZ234227A (en) * | 1989-06-30 | 1991-08-27 | Smithkline Beecham Corp | Delayed release dosage form |
| GB8915716D0 (en) * | 1989-07-08 | 1989-08-31 | Coopers Animal Health | Pharmaceutical compositions |
| AU2021396978A1 (en) | 2020-12-08 | 2023-02-23 | Ruminant Biotech Corp Limited | Improvements to devices and methods for delivery of substances to animals |
-
1972
- 1972-04-19 ZA ZA722664A patent/ZA722664B/xx unknown
- 1972-04-27 IE IE562/72A patent/IE36335B1/xx unknown
- 1972-05-09 ES ES402545A patent/ES402545A1/es not_active Expired
- 1972-05-10 BE BE783321A patent/BE783321A/xx not_active IP Right Cessation
- 1972-05-10 NL NL7206328A patent/NL7206328A/xx not_active Application Discontinuation
- 1972-05-15 AU AU42309/72A patent/AU470023B2/en not_active Expired
- 1972-05-17 CA CA142,402A patent/CA997677A/en not_active Expired
- 1972-05-17 FR FR727217600A patent/FR2138011B1/fr not_active Expired
- 1972-05-18 DE DE2224390A patent/DE2224390A1/de active Pending
- 1972-05-18 GB GB2342672A patent/GB1330829A/en not_active Expired
Cited By (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2500307A1 (fr) * | 1981-02-23 | 1982-08-27 | Rech Applications Therap | Composition pharmaceutique antibiotique concue pour l'implantation dans une cavite naturelle, pathologique ou artificielle des tissus physiologiques, sa preparation et son utilisation |
| US4661339A (en) * | 1982-07-20 | 1987-04-28 | National Research Development Corp. | Sustained release composition |
| GB2155335A (en) * | 1984-03-07 | 1985-09-25 | Crb Virbac Sa | Device for sustained release of medicinal substances |
| US5190760A (en) * | 1989-07-08 | 1993-03-02 | Coopers Animal Health Limited | Solid pharmaceutical composition |
| AU781718B2 (en) * | 1999-11-02 | 2005-06-09 | Depomed, Inc. | Pharmacological inducement of the fed mode for enhanced drug administration to the stomach |
| EP1790334A3 (en) * | 1999-11-02 | 2008-02-20 | Depomed, Inc. | Pharmacological inducement of the fed mode for enhanced drug administration to the stomach |
| WO2001032217A2 (en) * | 1999-11-02 | 2001-05-10 | Depomed, Inc. | Pharmacological inducement of the fed mode for enhanced drug administration to the stomach |
| US7405238B2 (en) | 1999-11-02 | 2008-07-29 | Depomed Inc. | Pharmacological inducement of the fed mode for enhanced drug administration to the stomach |
| WO2001032217A3 (en) * | 1999-11-02 | 2002-07-18 | Depomed Inc | Pharmacological inducement of the fed mode for enhanced drug administration to the stomach |
| EP1790334A2 (en) * | 1999-11-02 | 2007-05-30 | Depomed, Inc. | Pharmacological inducement of the fed mode for enhanced drug administration to the stomach |
| US9597338B2 (en) | 2000-02-04 | 2017-03-21 | Depomed, Inc. | Shell-and-core dosage form approaching zero-order drug release |
| US7736667B2 (en) | 2000-02-04 | 2010-06-15 | Depomed, Inc. | Shell-and-core dosage form approaching zero-order drug release |
| US8043630B2 (en) | 2000-02-04 | 2011-10-25 | Depomed, Inc. | Shell-and-core dosage form approaching zero-order drug release |
| US8329215B2 (en) | 2000-02-04 | 2012-12-11 | Depomed, Inc. | Shell and core dosage form approaching zero-order drug release |
| US8945619B2 (en) | 2000-02-04 | 2015-02-03 | Depomed, Inc. | Shell-and-core dosage form approaching zero-order drug release |
| US6723340B2 (en) | 2001-10-25 | 2004-04-20 | Depomed, Inc. | Optimal polymer mixtures for gastric retentive tablets |
| US7976870B2 (en) | 2001-10-25 | 2011-07-12 | Depomed, Inc. | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
| US9980903B2 (en) | 2001-10-25 | 2018-05-29 | Depomed, Inc. | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
| US6682759B2 (en) | 2002-02-01 | 2004-01-27 | Depomed, Inc. | Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs |
| US9572780B2 (en) | 2003-07-18 | 2017-02-21 | Depomed, Inc. | Dual drug dosage forms with improved separation of drugs |
| US8999388B2 (en) | 2003-07-18 | 2015-04-07 | Depomed, Inc. | Dual drug dosage forms with improved separation of drugs |
| US8685450B2 (en) | 2003-07-18 | 2014-04-01 | Depomed, Inc. | Dual drug dosage forms with improved separation of drugs |
| CN104523636A (zh) * | 2014-12-25 | 2015-04-22 | 昆明振华制药厂有限公司 | 一种呋喃唑酮缓释片及其制备方法 |
| CN104523636B (zh) * | 2014-12-25 | 2017-07-18 | 昆明振华制药厂有限公司 | 一种呋喃唑酮缓释片及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2138011A1 (xx) | 1972-12-29 |
| NL7206328A (xx) | 1972-11-21 |
| FR2138011B1 (xx) | 1973-07-13 |
| ZA722664B (en) | 1973-01-31 |
| AU4230972A (en) | 1973-11-22 |
| DE2224390A1 (de) | 1973-12-13 |
| ES402545A1 (es) | 1975-04-01 |
| IE36335L (en) | 1972-11-18 |
| BE783321A (fr) | 1972-11-10 |
| CA997677A (en) | 1976-09-28 |
| AU470023B2 (en) | 1976-03-04 |
| IE36335B1 (en) | 1976-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3507952A (en) | Sustained release bolus for animal husbandry | |
| GB1330829A (en) | Layered bolus for animal husbandry providing for immediate and sustained release of medicament | |
| US3535419A (en) | Veterinary compositions and methods | |
| RU2100021C1 (ru) | Композиция для контролируемого равномерного освобождения активно действующего вещества для орального применения у жвачных животных и изделие, содержащее несколько препаративных форм | |
| US3056724A (en) | Therapeutic pellets for ruminants | |
| US4122157A (en) | Nitrofurantoin sustained release tablet | |
| US3655864A (en) | Glyceryl tristerate and higher fatty acid mixture for improving digestive absorption | |
| US4670248A (en) | Olivine bolus | |
| US4066754A (en) | Slow release bolus | |
| GB1022171A (en) | Prolonged release oral pharmaceutical tablets and their manufacture | |
| CZ281577B6 (cs) | Způsob přípravy přípravků ve formě tablet nebo dražé, obsahujících účinnou látku citlivou na světlo,teplo a vlhkost, mající monoklinickou krystalovou strukturu | |
| CA1326998C (en) | Veterinary treatment | |
| US4076803A (en) | Synergistic combination of metal proteinates with beta-chlorovinyl dialkyl phosphates | |
| Todd et al. | Parathyroid action on calcium, phosphorus, magnesium, and citric acid in dairy cattle | |
| CA1275931C (en) | Agent for improving the fertility of mammals and process for producing same | |
| US20020037317A1 (en) | Wax bolus | |
| US3860723A (en) | Methods and compositions for increasing feed intake of animals | |
| GB1302266A (xx) | ||
| AP105A (en) | Treatment of animals. | |
| GB1176196A (en) | Improvements in or relating to Animal Feeding Stuffs | |
| US3754082A (en) | Process and composition for botfly larvae eliminination | |
| JP2575008B2 (ja) | 動物用医薬品組成物 | |
| US3740423A (en) | Protection of the colon of mammals during treatment with antibiotics by simultaneous administration of nystatin and torulopsis tropsis | |
| Kennedy | Sheep health-an update | |
| Tilton et al. | Controlled Mating In Beef Cows |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PE20 | Patent expired after termination of 20 years |